Previous reports of HHT-PAH linked to ACVRL1 variants have all involved heterozygotes and include multiple cases within the same family, often with childhood-onset presentations, compared to PAH of other etiologies (Soubrier et al., 2013). This evidence concerns the gene ACVRL1 and pulmonary arterial hypertension.